Levofloxacin, Bismuth, Amoxicillin and Esomeprazole As Second-Line Helicobacter pylori Therapy After Failure of Non-Bismuth Quadruple Therapy

被引：0
|
作者：
Song, Zhiqiang
Zhou, Liya
机构：
来源：
GASTROENTEROLOGY | 2016年 / 150卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(16)32965-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1340
引用
收藏
页码：S879 / S879
页数：1
相关论文
共 50 条
  • [31] Prospective comparative study between two first-line regimens for Helicobacter pylori eradication: Non-bismuth quadruple versus bismuth quadruple therapy
    Alcedo, Javier
    Gracia, Marta
    Garcia-Camara, Paula
    Palacin, Carmen
    Gallego, Sonia
    Jimeno-Ayllon, Cristina
    Frago, Santiago
    Aured, Isabel
    Luzon, Lara
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2020, 43 (06): : 301 - 309
  • [32] LEVOFLOXACIN/AMOXICILLIN-BASED REGIMENS VERSUS QUADRUPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION IN SECOND-LINE: A METANALYSIS
    Di Caro, S.
    Fini, L.
    Daoud, Y.
    Laghi, L.
    Gasbarrini, A.
    Mccartney, S.
    Bloom, S.
    DIGESTIVE AND LIVER DISEASE, 2011, 43 : S161 - S161
  • [33] LEVOFLOXACIN SEQUENTIAL THERAPY VERSUS BISMUTH QUADRUPLE THERAPY IN THE SECOND-LINE AND THIRD-LINE TREATMENT OF HELICOBACTER PYLORI INFECTION- A MULTICENTER RANDOMIZED TRIAL
    Liou, Jyh-Ming
    Chen, Chieh-Chang
    Fang, Yu-Jen
    Chen, Po-Yueh
    Lin, Jaw-Town
    Wu, Ming-Shiang
    GASTROENTEROLOGY, 2020, 158 (06) : S570 - S570
  • [34] Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection
    Wong, WM
    Gu, Q
    Chu, KM
    Yee, YK
    Fung, FMY
    Tong, TSM
    Chan, AOO
    Lai, KC
    Chan, CK
    Wong, BCY
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (03) : 421 - 427
  • [35] Effectiveness and Safety of Repeated Quadruple Therapy in Helicobacter pylori Infection After Failure of Second-line Quadruple Therapy
    Lee, Sang Kyu
    Lee, Sang Woo
    Park, Jae Yeon
    Kwon, Bo Sung
    Kim, Seung Young
    Hyun, Jong Jin
    Kim, Jeong Han
    Jung, Sung Woo
    Koo, Ja Seol
    Yim, Hyung Joon
    Choi, Jai Hyun
    HELICOBACTER, 2011, 16 (05) : 410 - 414
  • [36] Comparison of 10 day bismuth quadruple therapy with high-dose metronidazole or levofloxacin for second-line Helicobacter pylori therapy: a randomized controlled trial
    Kuo, Chao-Hung
    Hsu, Ping-I
    Kuo, Fu-Chen
    Wang, Sophie S. W.
    Hu, Huang-Ming
    Liu, Chung-Jung
    Chuah, Seng-Kee
    Chen, Yen-Hsu
    Hsieh, Ming-Chia
    Wu, Deng-Chyang
    Tseng, Hui-Hwa
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (01) : 222 - 228
  • [37] Helicobacter pylori Eradication Rates and Related Factors by Second-Line Bismuth-Based Quadruple Therapy
    Kim, Sung Eun
    Park, Moo In
    Park, Seun Ja
    Moon, Won
    Lee, Jun Yeob
    Lee, Jin Wook
    Kim, Hae Koo
    Nam, Kyoung Sik
    Nam, Yong Jin
    GASTROENTEROLOGY, 2016, 150 (04) : S881 - S881
  • [38] Amoxicillin in Replacement for Bismuth Subcitrate Offers Similar Helicobacter pylori Eradiation Response in Second-Line Rabeprazole-Based Quadruple Therapy
    Hu, Huang-Ming
    Hsu, Ping-I
    Chuah, Seng-Kee
    Liu, Meng-Kwan
    Kuo, Fu-Chen
    Kuo, Chao-Hung
    Wu, Deng-Chyang
    GASTROENTEROLOGY, 2012, 142 (05) : S485 - S485
  • [39] Letter: bismuth, levofloxacin, amoxicillin, PPI quadruple therapy is not an effective first or second-line regimen in the presence of levofloxacin resistance authors' reply
    Gisbert, J. P.
    Romano, M.
    Molina-Infante, J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (11) : 1221 - 1222
  • [40] Understanding treatment guidelines with bismuth and non-bismuth quadruple Helicobacter pylori eradication therapies
    Graham, David Y.
    Dore, Maria Pina
    Lu, Hong
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2018, 16 (09) : 679 - 687
12345